Carregant...
Chronic carbamazepine administration reduces NMDA receptor-initiated signaling via arachidonic acid in rat brain
BACKGROUND: Lithium and carbamazepine (CBZ) are used to treat mania in bipolar disorder. When given chronically to rats, both agents reduce brain arachidonic acid (AA) turnover in brain phospholipids and downstream AA metabolism. Lithium administration to rats also attenuates N-methyl-D-aspartic aci...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2131715/ https://ncbi.nlm.nih.gov/pubmed/17628508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2007.04.021 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|